| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.0078 |
0.9 |
| mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |